中文名称 | (8S,10S)-6,8,11-三羟基-10-(((2R,4S,5S,6S)-5-羟基-4-((S)-2-甲氧基吗啉基)-6-甲基四氢-2H-吡喃-2-基)氧基)-8-(2-羟基乙酰基)-1-甲氧基-7,8,9,10-四氢并四苯-5,12-二酮;奈莫柔比星 |
---|---|
英文名称 | Nemorubicin | Methoxymorpholinyldoxorubicin | PNU 152243 | PNU-152243A | | DMM Dox | MMRDX | FCE 23762 | PNU 152243 |
CAS号 | 108852-90-0 |
分子式 | C32H37NO13 |
分子量 | 643.64 |
MDL | MFCD00871079 |
外观 | Orange to reddish brown powder |
储存条件 | 4°C, protect from light |
Nemorubicin (Methoxymorpholinyl doxorubicin) is a Doxorubicin derivative with potent antitumor activity. Nemorubicin is highly cytotoxic to a variety of tumor cell lines presenting a multidrug-resistant phenotype. Nemorubicin not only intercalate into the duplex DNA, but also result in significant ligands for G-quadruplex DNA segments, stabilizing their structure. Nemorubicin requirs an intact nucleotide excision repair (NER) system to exert its activity .
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft